Search
for
Sort by
Research 391–420 of 416
- Demonstrating the potential of untargeted hair proteomics for personalized biomarkers in stress-associated disorders
- A Systematic Scoping Review and Conceptual Analysis of New-Onset Fibromyalgia Manifestations After Non-Hospitalized COVID-19: Empirics, Definitions, Methodologies, Pathophysiology, Mapping of Literature, and Knowledge Gaps
- The Effects of FemmeBalance Supplement on Symptoms of Premenstrual Syndrome: A Four-Cycle Single-Arm Observational Study of a Novel Nutritional Supplement
- Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis
- Mendelian randomization studies of testosterone exposure: A systematic review
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Clinical case of alopecia totalis in pediatric practice
- Identification of Various Deficiencies Using Data Mining Techniques - A Survey
- Hypersensitivity Reactions to Homemade Topical Preparations.
- Alopecia
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- Alopecia Areata in Underrepresented Groups: Preliminary Analysis of the All of Us Research Program
- Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional
- Scaly Papular Lesions
- Prevalence of skin disorders in Sari, 2003-2004
- The Effect of the COVID-19 Pandemic on Stress-related Dermatologic Diseases.
- The relationship of depression, alcohol and marijuana with treatment for LUTS/BPH.
- Early Onset of Central Centrifugal Cicatricial Alopecia (CCCA) in Pediatric Patients: An Underrecognized Diagnosis
- LB919 Increased risk of skin cancer and other malignancies in patients with cutaneous lupus erythematous
- Effects Of Hormone Therapy On The Laboratory Profile Of Transgender People: A Scoping Review
- 50832 Confetti variant of Alopecia Areata: A Single Center Retrospective Study to Describe a Novel Entity
- Endocrine intervention for transsexuals
- FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire/Function in Women
- Role of Oxidative Stress in Obese and Nonobese PCOS Patients
- Scalp Involvement in Primary Cutaneous Lymphomas—An Update on Clinical Presentation, Diagnostics, and Management
- Covid-19, Diagnostic History and Mortality from Medicare 1999-2021, In an All-Cause Mortality Approach
- Proposed ICD-10 framework for identifying emergency department visits that may be impacted by community pharmacy care clinics
- Incidence and Factors Associated With Androgenetic Alopecia Among Transgender and Gender-Diverse Patients Treated With Masculinizing Hormone Therapy
- Prevalence and incidence of primary lymphocytic cicatricial alopecias in the United States from 2019 to 2024
- Validation of alopecia coding in US claims data among women of childbearing age